$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
类风湿关节炎新药巴瑞克替尼
2025-10-19 11:44:20
Check Details
类风湿关节炎患者服用巴瑞克替尼的临床数据
2025-10-19 11:44:20
Check Details
巴瑞克替尼治疗类风湿关节炎超过两年后的安全性
2025-10-19 11:44:20
Check Details
甲氨蝶吟治疗欠佳的RA患者可服用巴瑞克替尼
2025-10-19 11:44:20
Check Details
巴瑞克替尼治疗类风湿关节炎疗效明显优于甲氨蝶吟
2025-10-19 11:44:20
Check Details
托法替尼类风湿关节炎患者的抑制剂
2025-10-19 11:44:20
Check Details
托法替布类风湿关节炎抑制剂
2025-10-19 11:44:20
Check Details
托法替尼(Tofanib)
2025-10-19 11:44:20
Check Details
托法替尼治疗类风湿性关节炎的疗效
2025-10-19 11:44:20
Check Details
托法替尼治疗类风湿关节炎患者安全有效
2025-10-19 11:44:20
Check Details
托法替尼,类风湿关节炎治疗药物
2025-10-19 11:44:20
Check Details
托法替尼治疗银屑病患者
2025-10-19 11:44:20
Check Details
1
2
...
2649
2650
2651
2652
2653
2654
2655
...
10228
10229
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Asciminib (Scemblix): Targeted Mechanism, Dosing Regimens, and Missed-Dose Guidance
2
Vigabatrin (Sabril): Mechanism of Action, Pharmacokinetics, and Safety Monitoring
3
Belzutifan (WELIREG) Treatment Guide: Duration, Onset of Action, and Monitoring Protocol
4
Lapatinib Side Effects: Managing Diarrhea, Skin Reactions, and Liver Function Changes
5
Trelagliptin: A Once-Weekly Long-Acting Oral DPP-4 Inhibitor
6
Neurokinin Receptor Antagonists: A Non-Hormonal Approach to Menopausal Hot Flashes and Sleep Disturbances
7
Cemiplimab: A PD-1 Checkpoint Inhibitor for Skin Cancers and Non-Small Cell Lung Cancer
8
Nintedanib: A Multi-Target Antifibrotic Agent for Slowing Pulmonary Fibrosis Progression
9
Capmatinib (Tabrecta): Generational Positioning, Adverse Effect Incidence, and Comprehensive Management
10
Gilteritinib (XOSPATA): Dosing Cycle, Treatment Duration, and Development Background
11
Dabrafenib (TAFINLAR): Indications, Adverse Effect Management, and Dose Modification Guide
12
Adagrasib (Krazati): A Complete Guide to Side-Effect Recognition and Grade-Based Management